Get the Stockscreener App
4.21
1.45%
0.06
After Hours:
4.21
Apyx Medical Corp stock is traded at $4.21, with a volume of 86,801.
It is up +1.45% in the last 24 hours and up +3.95% over the past month.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
See More
Previous Close:
$4.15
Open:
$4.15
24h Volume:
86,801
Relative Volume:
0.49
Market Cap:
$176.29M
Revenue:
$52.84M
Net Income/Loss:
$-11.11M
P/E Ratio:
-15.35
EPS:
-0.2742
Net Cash Flow:
$-9.12M
1W Performance:
-8.68%
1M Performance:
+3.95%
6M Performance:
+15.34%
1Y Performance:
+139.20%
1-Day Range:
$4.15
$4.30
1-Week Range:
$4.15
$4.99
52-Week Range:
$1.5902
$5.08
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
(727) 384-2323
Address
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
4.21 | 192.62M | 52.84M | -11.11M | -9.12M | -0.2742 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-25 | Initiated | Roth Capital | Buy |
| Nov-14-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Nov-12-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Oct-17-24 | Initiated | BTIG Research | Neutral |
| Jul-14-23 | Initiated | Stephens | Overweight |
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
View All
Apyx Medical Corp Stock (APYX) Latest News
Apyx Medical (NASDAQ: APYX) director receives grant of 50,000 stock options - Stock Titan
Apyx Medical (APYX) CFO awarded 132,066 stock options at $4.65 - Stock Titan
Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike - Stock Titan
Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units - Stock Titan
Apyx Medical (NASDAQ: APYX) CEO awarded 213,948 stock options - Stock Titan
Apyx Medical (NASDAQ: APYX) COO awarded stock options on 88,044 shares - Stock Titan
[Form 4] Apyx Medical Corp Insider Trading Activity - Stock Titan
Apyx Medical (NASDAQ: APYX) director receives 50,000 stock options at $4.65 strike - Stock Titan
Apyx Medical Corp. Hits New 52-Week High of $4.65 - Markets Mojo
Apyx Medical Corp. Hits New 52-Week High of $4.97, Up 198% - Markets Mojo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
APYX Q1 2026 Earnings: EPS Beats Expectations Despite Revenue UncertaintyEarnings Momentum Score - The Legal Advocate
APYX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise But Stock DeclinesROIC Trend Report - The Legal Advocate
APYX Technical Analysis | Trend, Signals & Chart Patterns | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout
Apyx Medical reports clinical data on cellulite treatment - Investing.com
One-session cellulite study shows visible dimple reduction, tighter skin - Stock Titan
APYX Stock Price, Quote & Chart | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
Why Apyx Medical (APYX) Just Dropped -6.88% — What to Watch 2026-05-15Popular Market Picks - newser.com
TradingKey - TradingKey
Apyx Medical Announces Positive Clinical Outcomes for Renuvion and Launches AYON Body Contouring System in May 2026 - Minichart
Apyx Medical study shows improved satisfaction with Renuvion - Investing.com
Apyx Medical study: Renuvion with liposuction shows higher patient satisfaction, lower revision and abdominoplasty rates - TradingView
Apyx Medical (NASDAQ: APYX) study shows Renuvion boosts liposuction satisfaction - Stock Titan
New 113-patient study links Renuvion lipo to fewer repeat surgeries - Stock Titan
Apyx Medical receives FDA clearance for power liposuction feature By Investing.com - Investing.com South Africa
Apyx Medical Corporation Files Form 8-K Reporting Company Information and SEC Compliance Details - Minichart
Apyx Medical receives FDA clearance for power liposuction feature - Investing.com
Apyx Medical receives FDA 510(k) expansion for AYON to add power liposuction - TradingView
[8-K] Apyx Medical Corp Reports Material Event - Stock Titan
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System - ChartMill
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50 - Yahoo Finance
Apyx Medical Corporation (NASDAQ:APYX) Q1 2026 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp 2026 Q1 Financial Results: Key Highlights, Net Loss, and Business Developments - Minichart
Apyx raises 2026 revenue outlook to $59M-$60M as AYON demand ramps - MSN
Apyx Medical (NASDAQ: APYX) grows Q1 2026 sales 32%, narrows loss - Stock Titan
NewBeauty Award Win Keeps Attention on Apyx Medical’s Renuvion Growth Strategy - Yahoo Finance
Earnings call transcript: Apyx Medical Q1 2026 beats expectations, stock surges - Investing.com
APYX MEDICAL CORP (NASDAQ:APYX) Surges After Q1 Beat - ChartMill
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
International demand helps Apyx raise 2026 sales target to $60M - Stock Titan
Apyx Medical (APYX) lifts 2026 outlook as Q1 sales jump 32% - Stock Titan
Apyx Medical Corporation Reports First Quarter 2026 Financial Results - ChartMill
How The Apyx Medical (APYX) Story Is Shifting With 2026 Guidance And New Growth Drivers - Yahoo Finance
APYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class ActionAPYX - TMX Newsfile
Weight-loss revolution sparks new appetite for aesthetics firms - Yahoo Finance
1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC - MarketBeat
Earnings Preview: Apyx Medical to Report Financial Results Pre-market on May 07 - Moomoo
Apyx Medical (APYX) Expected to Announce Earnings on Thursday - MarketBeat
Apyx Medical Corp Stock (APYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Apyx Medical Corp Stock (APYX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Roman Shawn David | Chief Operating Officer |
Jan 27 '26 |
Option Exercise |
1.80 |
12,000 |
21,600 |
12,000 |
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):